Vibliome Therapeutics Revenue

Pharmaceutical Manufacturing • Bozeman, Montana, United States • 1-10 Employees

Vibliome Therapeutics revenue & valuation

Annual revenue	$3,900,000
Revenue per employee	$1,300,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$12,500,000
Total funding	$38,000,000

Key Contact at Vibliome Therapeutics

Patrick Green

Director, Information Technology

Company overview

Headquarters	400 E Babcock St, Bozeman, Montana 59715, US
Phone number	+14065953483
Website	vibliome.com
NAICS	3254
Keywords	Biotechnology, Research, Oncology, Kinase Inhibitors
Founded	2017
Employees	1-10
Socials

Vibliome Therapeutics Email Formats

Vibliome Therapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@vibliome.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@vibliome.com	100%

About Vibliome Therapeutics

Vibliome Therapeutics, LLC, developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity. There are over 500 kinases in the human genome which control nearly all cellular functions by transferring a polar phosphate group from ATP to regulatory serine, threonine, or tyrosine residues on proteins.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore Vibliome Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-03-24	4	$38,000,000

Funding Insights

$38,000,000

Total funding amount

$38,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Vibliome Therapeutics is located in Bozeman, Montana, US.

You can reach Vibliome Therapeutics at +14065953483.

Vibliome Therapeutics generates an estimated annual revenue of $3,900,000. This revenue figure reflects the company's market position and business performance in its industry.

Vibliome Therapeutics has an estimated valuation of $12,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Vibliome Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Vibliome Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Vibliome Therapeutics has raised a total of $38,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Vibliome Therapeutics

Patrick Green

Director, Information Technology

4.8

40,000 users